It makes clear who will be calling all the shots.

It makes clear who will be calling all the shots. Also, as of June 14, 2021, the registrant had 100,300,000 shares outstanding so it appears that number hasnt changed since 2021.

So my guess is shareholders havent been diluted since June 2021 or through this BK. Id take that as pretty good stuff for current shareholders

Quote:

---

Beijing Youfeng Biological Technology Co., Ltd. owns 64,153,151 common stock shares of NuGenerex Immuno-Oncology, Inc. (approximately 63.96%)
and 100,000 shares, or 100%, of its Series A Super Voting Preferred Stock.

* Per the Sale Order by the United States Bankruptcy Court, Southern District of Florida, Fort Lauderdale Division on February 7, 2023, Beijing Youfeng
Biological Technology Co., Ltd. and the Chapter 7 Trustee allocate the purchase price of $3.35 million for the equity and assigned claims of Generex Biotechnology Corporation such as they agree.

---